India is the biggest manufacturer of the anti-malarial drug that is being touted as game changer in the fight against the Covid-19 pandemic.
The government on Friday said that there is enough stock of hydroxychloroquine (HCQ) in the country and it is taking all steps to ensure that there is no shortage of the drug in the domestic market.
Joint Secretary in the Ministry of Health Lav Agarwal said that India has a stock of 3.28 crore tablets of hydroxychloroquine, which is three time more than the projected requirement of one crore tablets in the country for the coming week and that tie-ups have been made for additional supply of 2 to 3 crore tablets for the future need.
“Based on our projected requirement, we need one crore tablets of hydroxychloroquin for the coming one week, while we have 3.28 crore tablets with
First Published: Apr 11 2020 | 12:57 PM IST